京东健康上半年营收409亿 增长主要由医药和健康产品收入驱动

This article highlights JD Health's interim results for the first half of 2026 and its latest business updates, with key takeaways as follows:

1. Core financial performance: JD Health posted total revenue of 40.888 billion yuan in H1 2026, up 15.9% year-on-year. Gross profit reached 10.686 billion yuan, an increase of 20.2%. Operating profit hit 3.174 billion yuan, rising 49.2%, while adjusted operating profit under non-IFRS stood at 3.483 billion yuan, up 40.3% year-on-year. Its operating margin increased from 7.0% to 8.5%, with profit growth far outpacing revenue growth, delivering a strong performance.

2. Growth drivers: The overall growth was primarily led by revenue from pharmaceuticals and health products, which climbed from 29.3 billion yuan in the same period last year to 33.9 billion yuan, a 15.6% year-on-year increase. This growth was fueled by a growing active user base, incremental purchases from existing users, rising online penetration, and expanded product categories.

3. New business developments: JD Health is currently rolling out AI across all business scenarios in a coordinated multi-business strategy, covering Internet medical care, offline services, and smart healthcare.

This article outlines the latest trends in the online big health industry, providing strategic insights for big health brands, with key takeaways as follows:

1. Consumption and channel trends: Online penetration of pharmaceutical and health products continues to rise, and the online channel still maintains double-digit growth. JD Health’s revenue from this segment reached 33.9 billion yuan in H1 2026, up 15.6% year-on-year, indicating there is still substantial room for incremental growth for brands that expand their online channel布局.

2. Shifting user characteristics: Growth comes from a growing active user base and incremental spending per user, which shows consumers have formed the habit of purchasing health products online, and user lifetime value still has room to grow. Brands can unlock further growth through refined user operations.

3. New industry directions: AI has been deployed across all big health scenarios, covering specialized disease diagnosis assistance, health management and other fields. Brands can upgrade their products and services by integrating AI capabilities, and tap into broader business boundaries by connecting with the AI ecosystem of leading industry platforms.

This article offers insights into market trends and opportunities for online big health sellers, with key takeaways as follows:

1. Overall market conditions: The online big health sector still maintains relatively strong growth. JD Health’s overall revenue rose 15.9%, with profit growth approaching 50%, and the sector’s overall profitability continues to improve. This remains a growing market with abundant incremental opportunities for new entry and business expansion.

2. Untapped growth opportunities: Core industry growth drivers include growing active users, rising purchase frequency and average order value, increasing online penetration, and category expansion. Sellers can unlock incremental growth by expanding into niche categories and deepening user operations.

3. Platform ecosystem dividends: JD Health is currently expanding AI-powered full-scenario services and布局 offline comprehensive outpatient clinics, continuously improving its platform ecosystem to provide sellers with traffic and service support. Sellers can gain more exposure and conversion opportunities by leveraging the platform’s new business initiatives.

This article outlines industry demand and transformation directions for health product manufacturers, with key takeaways as follows:

1. Overall business opportunities: Online demand for pharmaceutical and health products still maintains growth of over 15%, with online penetration continuing to rise, leaving substantial incremental room in the online market. Manufacturers can increase production of products adapted to online consumer demand and expand online channels to capture growth dividends.

2. Product development direction: JD Health’s revenue growth has benefited from category expansion, indicating there is still market opportunity for diversified niche health products. Manufacturers can develop more segmented health products aligned with online consumer habits to match online demand.

3. Digital transformation insights: The big health industry is now fully advancing AI-powered digital adoption. Manufacturers can leverage the digital capabilities of leading platforms to upgrade digitalization in their production and sales processes, strengthen cooperation with leading platforms like JD Health, and improve their own market competitiveness.

This article covers industry trends and client demand directions for service providers in the big health sector, with key takeaways as follows:

1. Industry development trends: The online big health sector is currently in a period of steady growth. Leading platform JD Health posted 15.9% revenue growth in H1 2026, with operating profit growing 49.2%—far outpacing revenue growth. The sector’s overall profitability continues to improve, with ample market space and ongoing upward momentum.

2. Core client demand: Leading platforms have begun rolling out AI across all business scenarios, covering Internet medical assisted diagnosis and treatment, offline health services, AI-powered health management, hospital clinical services and other use cases. AI-enabled big health has become a clear industry direction, creating substantial demand for both AI technology service providers and medical service providers.

3. Business development direction: The industry currently needs tailored AI solutions for different scenarios, including specialized disease AI models, AI-powered long-term health management, and clinical pharmacy management. Service providers can develop targeted solutions for these segmented scenarios to meet the demand of leading platforms and medical institutions.

This article presents the latest developments of leading online health platform JD Health, offering a reference for peer platforms, with key takeaways as follows:

1. Latest platform operations and布局: JD Health is advancing coordinated full-scenario AI deployment across multiple businesses. In Internet healthcare, it has co-built specialized disease AI models with leading top-tier public hospitals, and launched "JD Zhi Yi" to provide assisted diagnosis support for connected Internet hospitals. For smart healthcare, it upgraded the functionality of its AI doctor "Da Wei" and launched "JD Zhuo Yi" to cover hospital clinical services. It is also expanding offline comprehensive outpatient clinics covering physical examinations, dentistry and medical aesthetics, pursuing an integrated online-offline growth strategy.

2. Growth path reference: Platforms can anchor their core retail business for pharmaceutical and health products, capture the industry dividend of rising online penetration, drive growth by expanding categories, acquiring new users and increasing per-user value, and boost profitability by expanding into medical services.

3. Strategic direction reference: AI plus healthcare is a clear industry trend. Platforms can proactively deploy AI across scenarios, expand business boundaries by integrating offline services, improve overall platform competitiveness, and leverage the advantages of their core retail business to support the development of innovative new businesses.

This article provides the latest operating data and industry trends from a leading industry player for researchers focused on the Internet health industry, with key takeaways as follows:

1. Latest industry profitability data: Leading platform JD Health posted H1 2026 revenue of 40.888 billion yuan, up 15.9% year-on-year, with operating profit growing 49.2% year-on-year, and operating margin increasing 1.5 percentage points. This demonstrates the Internet health industry has entered a phase of profit realization, its mainstream business models are proven viable, and profitability continues to improve.

2. Latest industry developments: Leading industry players have now entered the stage of commercial full-scenario deployment of AI, with AI already applied to assisted diagnosis, health management, clinical services and multiple other segmented scenarios. During the 2026 618 shopping festival, service volume from AI doctors grew nearly fourfold year-on-year, confirming that AI plus healthcare has moved from concept-driven investment to commercial application.

3. Industry growth logic: Industry growth is still primarily driven by the online penetration of pharmaceutical and health product retail, while the medical service segment is gradually maturing. A diversified coordinated business model combining retail, medical services and AI enabling has taken shape, providing a typical case study for research on the future direction of the industry.